CVE-2026-50034

Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information

CVSS 7.1 HIGHEPSS 0.1%CWE-319

Vexday Risk Score

21Baixo

Decisão SSVC (CISA)

Track

Sem sinal de exploração → monitorar

CVSS 7.1EPSS 0.1%KEV nãoPoC —Nuclei —Metasploit —Patch —

Ciclo de vida

18 jun 2026Publicada no NVD

Recomendação: Monitorar — sem sinal de exploração no momento.

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N

Produtos afetados

Apollo Pharmacy · Blood Glucose Monitoring System (Model No. APG-01 BT)

Quer saber se a sua infraestrutura está exposta a isto?

Falar com a TrueHacking →

Referências

https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json https://www.apollopharmacy.in/contact-us https://www.cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01 https://www.cisa.gov/news-events/news/understanding-bluetooth-technology